Ozkan M - Search Results

1

Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin.

Dogu GG, Ozkan M, Ozturk F, Dikilitas M, Er O, Ozturk A. Dogu GG, et al. Among authors: ozkan m. Med Oncol. 2010 Mar;27(1):34-9. doi: 10.1007/s12032-009-9166-3. Epub 2009 Jan 21. Med Oncol. 2010. PMID: 19156550

2

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer.

Altinbas M, Coskun HS, Er O, Ozkan M, Eser B, Unal A, Cetin M, Soyuer S. Altinbas M, et al. Among authors: ozkan m. J Thromb Haemost. 2004 Aug;2(8):1266-71. doi: 10.1111/j.1538-7836.2004.00871.x. J Thromb Haemost. 2004. PMID: 15304029 Free article. Clinical Trial.

3

Meropenem +/- granulocyte colony stimulating factor in the treatment of febrile neutropenic patients with cancer: prospective randomized study.

Er O, Coskun HS, Altinbas M, Ozkan M, Eser B, Cetin M, Altuntas F, Unal A. Er O, et al. Among authors: ozkan m. J Chemother. 2004 Jun;16(3):288-92. doi: 10.1179/joc.2004.16.3.288. J Chemother. 2004. PMID: 15330327 Clinical Trial.

4

Post-operative sequential chemo-radiotherapy in high-grade cerebral gliomas with fotemustine.

Ozkan M, Altinbas M, Er O, Kaplan B, Coskun HS, Karahacioglu E, Menku A, Cihan Y, Kontas O, Akdemir H. Ozkan M, et al. J Chemother. 2004 Jun;16(3):298-302. doi: 10.1179/joc.2004.16.3.298. J Chemother. 2004. PMID: 15330329

5

Antiphospholipid syndrome associated with malignant mesothelioma presenting with superior vena cava thrombosis: a case report.

Ozkan M, Eser B, Er O, Altuntas F, Coskun R, Topsakal R, Mavili E, Kala M, Altinbas M. Ozkan M, et al. Clin Appl Thromb Hemost. 2004 Oct;10(4):393-6. doi: 10.1177/107602960401000413. Clin Appl Thromb Hemost. 2004. PMID: 15497027 Free article.

6

Preliminary results of a phase II study of weekly paclitaxel (PTX) and carboplatin (CBDCA) administered concurrently with thoracic radiation therapy (TRT) followed by consolidation chemotherapy with PTX/CBDCA for stage III unresectable non-small-cell lung cancer (NSCLC).

Kaplan B, Altýnbas M, Eroglu C, Karahacioglu E, Er O, Ozkan M, Bilgin M, Canoz O, Gulmez I, Gulec M. Kaplan B, et al. Among authors: ozkan m. Am J Clin Oncol. 2004 Dec;27(6):603-10. doi: 10.1097/01.coc.0000135739.37072.ff. Am J Clin Oncol. 2004. PMID: 15577439 Clinical Trial.

7

Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma: results of a single center in central anatolia.

Altinbas M, Er O, Ozkan M, Coskun HS, Gulmez I, Ekici E, Kaplan B, Eser B, Ozesmi M. Altinbas M, et al. Among authors: ozkan m. Med Oncol. 2004;21(4):359-66. doi: 10.1385/MO:21:4:359. Med Oncol. 2004. PMID: 15579920 Clinical Trial.

8

Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?

Ozkan M, Eser B, Er O, Dogu GG, Altinbas M. Ozkan M, et al. J Clin Oncol. 2005 Mar 20;23(9):2113; author reply 2113-4. doi: 10.1200/JCO.2005.05.245. J Clin Oncol. 2005. PMID: 15774812 No abstract available.

9

Irinotecan plus cisplatin combination against metastatic gastric cancer: phase II study.

Altinbas M, Er O, Ozkan M, Solak Y, Coskun HS, Kucuk C, Gursoy S. Altinbas M, et al. Among authors: ozkan m. Med Oncol. 2005;22(2):153-60. doi: 10.1385/MO:22:2:153. Med Oncol. 2005. PMID: 15965278 Clinical Trial.

10

Squamous cell carcinoma of colorectal cancer: adjuvant radiotherapy is necessary?

Dogu GG, Ozkan M, Er O, Eser B, Altinbas M. Dogu GG, et al. Among authors: ozkan m. Eur J Cancer Care (Engl). 2005 Dec;14(5):465. doi: 10.1111/j.1365-2354.2005.00613.x. Eur J Cancer Care (Engl). 2005. PMID: 16274470 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,009 results

Search Page

Filters